2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: The Huntington’s Disease-Behavioral Questionnaire (HD-BQ): A New Screening Tool for Behavioral Disturbances in HD

J. Corey-Bloom, S. Aboufadel, I. Beltran-Najera, C. Snell, M. Williams, P. Gilbert (La Jolla, CA, USA)

Huntington’s Disease · Agora 3 West, Level 3

1:45pm-3:15pm: The impact of clinical care coordination on patient quality of life in the Atypical Parkinsonism clinic

M. Harris, J. Donnelly, L. Massey, B. Ghosh (Southampton, United Kingdom)

Quality of Life · Les Muses Terrace, Level 3

1:45pm-3:15pm: The Impact of Parkinson’s Disease to Quality of Life

R. Pinzon, RDL. Sanyasi (Yogyakarta, Indonesia)

Quality of Life · Les Muses Terrace, Level 3

1:45pm-3:15pm: The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Caregivers

T. Xie, X. Ye, J. de Courcy, K. Golden, Y. Bao, J. Zamudio, L. Chiodo, J. Morgan (Mettawa, IL, USA)

Caregiver Burden · Les Muses Terrace, Level 3

1:45pm-3:15pm: The influence of gender, associated neurological disorder and motive for polysomnography (PSG) in the manifestations of REM sleep behaviour disorder (RBD)

P. Bugalho, M. Salavisa (Lisbon, Portugal)

Restless Leg Syndrome, RBD and Other Sleep Disorders · Les Muses Terrace, Level 3

1:45pm-3:15pm: The influence of relationship quality on health-related quality of life when coping with Parkinson’s disease: a mediation analysis

M. Karlstedt, SM. Fereshtehnejad, D. Aarsland, J. Lökk (Huddinge, Sweden)

Quality of Life · Les Muses Terrace, Level 3

1:45pm-3:15pm: The longevity gene Klotho and its CSF protein profiles as modifier for Parkinson´s disease in a longitudinal study

M. Zimmermann, S. Lerche, C. Schulte, I. Wurster, G. Machetanz, C. Deuschle, A. Hauser, T. Gasser, D. Berg, E. Schleicher, W. Maetzler, K. Brockmann (Tuebingen, Germany)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: The mGlu2/3 orthosteric antagonist LY-341,495 abolishes the anti-dyskinetic and anti-psychotic effects of the mGlu2 positive allosteric modulator LY-487,379 in the MPTP-lesioned marmoset

A. Hamadjida, S. Nuara, J. Gourdon, P. Huot (Montreal, QC, Canada)

Neuropharmacology · Les Muses Terrace, Level 3

1:45pm-3:15pm: The PLA2G6 Gene Mutation Causes Parkinson’s Disease: A Case Report

L. Kou, T. Wang, L. Liu, GX. Zhang (Wuhan, China)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: The potential modifier effect of C9orf72 DNA methylation in C9ORF72 carriers

JM. Laffita-Mesa, CH. Kreidy, M. Paucar, P. Svenningsson (Stockholm, Sweden)

Genetics · Les Muses Terrace, Level 3